American Portfolios Advisors Autolus Therapeutics PLC Transaction History
American Portfolios Advisors
- $2.36 Trillion
- Q3 2022
A detailed history of American Portfolios Advisors transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, American Portfolios Advisors holds 16,925 shares of AUTL stock, worth $59,406. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,925Holding current value
$59,406% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding AUTL
# of Institutions
115Shares Held
167MCall Options Held
34.2KPut Options Held
19.5K-
Syncona Portfolio LTD Guernsey, Channel Islands, X021.3MShares$74.9 Million86.45% of portfolio
-
Blackstone Inc New York, NY20.5MShares$71.9 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA17.9MShares$62.8 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT15.3MShares$53.6 Million1.74% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.3MShares$43.3 Million0.59% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $319M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...